Prospectus
Filed with ASX · · 46 pages · English
On 6ix: 6ix.com/news/prospectus-271
Story so far
Earlier from Argent Biopharma
- MGC pharma completes acquisition of telehealth platform MCC
- Further successful results from glioblastoma research
- Completion of phase II clinical trial on COVID-19 patients
- September Quarterly Activity and Cashflow Report
- Mgc pharma delivers record consecutive weekly sales growth
Later from Argent Biopharma
- ArtemiC Phase II Clinical Trial Results
- December Quarterly Activity and Cashflow Report
- MGC Pharma Investor Presentation
- MGC Pharma first medicinal cannabis company to list on LSE
- SwissPharmaCan AG increases initial purchase order
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma